Olema Pharmaceuticals Inc (NASDAQ: OLMA) open the trading on Thursday, with a bit cautious approach as it glided -3.15% to $9.83, before settling in for the price of $10.15 at the close. Taking a more long-term approach, OLMA posted a 52-week range of $3.93-$17.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -105.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -10.16%. This publicly-traded company’s shares outstanding now amounts to $54.99 million, simultaneously with a float of $48.58 million. The organization now has a market capitalization sitting at $549.60 million. At the time of writing, stock’s 50-day Moving Average stood at $12.03, while the 200-day Moving Average is $12.12.
Olema Pharmaceuticals Inc (OLMA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Olema Pharmaceuticals Inc’s current insider ownership accounts for 13.13%, in contrast to 86.76% institutional ownership. According to the most recent insider trade that took place on Mar 28 ’24, this organization’s Director sold 20,000 shares at the rate of 10.97, making the entire transaction reach 219,400 in total value, affecting insider ownership by 826,283. Preceding that transaction, on Feb 29 ’24, Company’s Director sold 25,000 for 12.41, making the whole transaction’s value amount to 310,309. This particular insider is now the holder of 846,283 in total.
Olema Pharmaceuticals Inc (OLMA) Earnings and Revenue Records
Olema Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -10.16% and is forecasted to reach -2.66 in the upcoming year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Let’s observe the current performance indicators for Olema Pharmaceuticals Inc (OLMA). It’s Quick Ratio in the last reported quarter now stands at 12.33. The Stock has managed to achieve an average true range (ATR) of 0.70.
In the same vein, OLMA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.16, a figure that is expected to reach -0.54 in the next quarter, and analysts are predicting that it will be -2.66 at the market close of one year from today.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
[Olema Pharmaceuticals Inc, OLMA] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 28.35% While, its Average True Range was 0.64.
Raw Stochastic average of Olema Pharmaceuticals Inc (OLMA) in the period of the previous 100 days is set at 6.46%, which indicates a major fall in contrast to 20.17% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 59.82% that was lower than 75.65% volatility it exhibited in the past 100-days period.
